跳至主要内容
临床试验/CTRI/2018/04/012988
CTRI/2018/04/012988招募中3 期

Early stoppage versus continuation of antimicrobial therapy in low risk pediatric cancer patients with febrile neutropenia, before recovery of counts: a randomized controlled study - DALFEN - study

All India Institute of Medical Sciences0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • oAll pediatric febrile neutropenia patients treated on outpatient basis with anticipated count recovery <= 10 days
  • oAge 3 years - 18 years
  • oFulfilling low risk criteria
  • (Hematological malignancies in remission, No identifiable focus of infection, No Pneumonia/ mucositis / GI sepsis / Nausea-vomiting/ neurologic-mental status changes/ CVC related infection, Anticipated ANC recovery < 10 days, No organ dysfunction, Hemodynamically stable, Culture negative )
  • oAfebrile for at least 24 hours, on intra-venous antibiotics

排除标准

  • oBone marrow involvement in solid tumor
  • oAlready enrolled once, in previous episode
  • oOn antibiotics prophylaxis
  • oRetroviral positive patients
  • oPatient undergone stem cell transplant

研究者

相似试验